Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Are the cardiometabolic complications of schizophrenia still neglected? Barriers to care.

Lambert TJ, Newcomer JW.

Med J Aust. 2009 Feb 16;190(4 Suppl):S39-42. Review.

PMID:
19220173
2.

Medical co-morbidity risk factors and barriers to care for people with schizophrenia.

Muir-Cochrane E.

J Psychiatr Ment Health Nurs. 2006 Aug;13(4):447-52. Review.

PMID:
16867129
3.
4.

Integrating general health care in private community psychiatry practice.

Goff DC.

J Clin Psychiatry. 2007;68 Suppl 4:49-54.

PMID:
17539701
5.

Which comes first: atypical antipsychotic treatment or cardiometabolic risk?

Stahl SM, Mignon L, Meyer JM.

Acta Psychiatr Scand. 2009 Mar;119(3):171-9. doi: 10.1111/j.1600-0447.2008.01334.x. Review.

PMID:
19178394
6.

Integrating general health care in private community psychiatry practice.

Goff DC, Newcomer JW.

J Clin Psychiatry. 2007 Jul;68(7):e19. Review.

PMID:
17685730
7.

Medical comorbidity in schizophrenia.

Lambert TJ, Velakoulis D, Pantelis C.

Med J Aust. 2003 May 5;178 Suppl:S67-70.

PMID:
12720526
8.

International Organization of Physical Therapy in Mental Health consensus on physical activity within multidisciplinary rehabilitation programmes for minimising cardio-metabolic risk in patients with schizophrenia.

Vancampfort D, De Hert M, Skjerven LH, Gyllensten AL, Parker A, Mulders N, Nyboe L, Spencer F, Probst M.

Disabil Rehabil. 2012;34(1):1-12. doi: 10.3109/09638288.2011.587090. Epub 2011 Sep 29. Review.

PMID:
21957908
10.

Metabolic comorbidity in schizophrenia.

Jacob R, Chowdhury AN.

Indian J Med Sci. 2008 Jan;62(1):23-31. Review.

PMID:
18239269
11.

BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment.

Cooper SJ, Reynolds GP; With expert co-authors (in alphabetical order):, Barnes T, England E, Haddad PM, Heald A, Holt R, Lingford-Hughes A, Osborn D, McGowan O, Patel MX, Paton C, Reid P, Shiers D, Smith J.

J Psychopharmacol. 2016 Aug;30(8):717-48. doi: 10.1177/0269881116645254. Epub 2016 May 4.

PMID:
27147592
12.

Overview of managing medical comorbidities in patients with severe mental illness.

McIntyre RS.

J Clin Psychiatry. 2009 Jun;70(6):e17.

PMID:
19573473
13.

[Assessment and control of metabolic and cardiovascular risk in patients with schizophrenia].

Rodríguez-Artalejo F, Baca E, Esmatjes E, Merino-Torres JF, Monereo S, Moreno B, Mories T, Roca M, Salvador J, Sanmartí A.

Med Clin (Barc). 2006 Oct 14;127(14):542-8. Review. Spanish. No abstract available.

PMID:
17145003
14.

Views of Australian mental health stakeholders on clients' problematic drug and alcohol use.

Cleary M, Hunt GE, Matheson S, Walter G.

Drug Alcohol Rev. 2009 Mar;28(2):122-8. doi: 10.1111/j.1465-3362.2008.00041.x.

PMID:
19320696
15.

Cardiometabolic Risks in Schizophrenia and Directions for Intervention, 2: Nonpharmacological Interventions.

Andrade C.

J Clin Psychiatry. 2016 Aug;77(8):e964-7. doi: 10.4088/JCP.16f11060. Review.

16.

Cardiovascular and metabolic risks in psoriasis and psoriatic arthritis: pragmatic clinical management based on available evidence.

Johnsson H, McInnes IB, Sattar N.

Ann Rheum Dis. 2012 Apr;71(4):480-3. doi: 10.1136/annrheumdis-2011-200567. Epub 2012 Jan 30. Review.

PMID:
22294632
17.
18.

Introduction: Balancing the equation: managing comorbidities in patients with severe mental illness.

McIntyre RS.

J Clin Psychiatry. 2009;70 Suppl 3:4. doi: 10.4088/JCP.7075su1c.01. No abstract available.

19.

[Schizophrenic patients' length of stay: clinical factors of variability and consequences].

Capdevielle D, Ritchie K, Villebrun D, Boulenger JP.

Encephale. 2009 Feb;35(1):90-6. doi: 10.1016/j.encep.2008.06.012. Epub 2008 Dec 18. Review. French.

PMID:
19250999
20.

Management of physical health in schizophrenia: a stepping stone to treatment success.

Millar H.

Eur Neuropsychopharmacol. 2008 May;18 Suppl 2:S121-8. doi: 10.1016/j.euroneuro.2008.02.002. Review.

PMID:
18346600

Supplemental Content

Support Center